anidulafungin has been researched along with clofarabine in 2 studies
| Studies (anidulafungin) | Trials (anidulafungin) | Recent Studies (post-2010) (anidulafungin) | Studies (clofarabine) | Trials (clofarabine) | Recent Studies (post-2010) (clofarabine) |
|---|---|---|---|---|---|
| 568 | 33 | 331 | 424 | 101 | 280 |
| Protein | Taxonomy | anidulafungin (IC50) | clofarabine (IC50) |
|---|---|---|---|
| cGMP-dependent 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 3.12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chan, TS; Chim, CS; Gill, H; Hwang, YY; Khong, PL; Kwong, YL; Leung, AY; Lie, AK; Loong, F; Sim, J; Tse, AC; Tse, E | 1 |
1 review(s) available for anidulafungin and clofarabine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for anidulafungin and clofarabine
| Article | Year |
|---|---|
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients.
Topics: Adenine Nucleotides; Adult; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Arabinonucleosides; Candida; Candidiasis, Invasive; Caspofungin; China; Clofarabine; Cohort Studies; Cross Infection; Echinocandins; Fusariosis; Fusarium; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lipopeptides; Lung Diseases, Fungal; Micafungin; Retrospective Studies; Risk Factors | 2014 |